Mark Drayson

Mark Drayson is a Professor actively engaged in translational research bridging immunology, hematological oncology, and clinical diagnostics. His work spans blood cancer therapy (notably myeloma and acute myeloid leukemia), immunodiagnostic test development, and investigation of immune modulation through behavioral interventions like exercise and stress management.

Current research themes include:

• Myeloma risk prediction via sphingolipid metabolism analysis
• Exercise-induced hematopoietic stem cell mobilization
• Vaccine response dynamics in aging and HIV populations
• Rapid diagnostic test implementation for myeloma
• Drug repurposing for hematological malignancies

His collaborations extend to Cancer Research UK, Myeloma UK, and interdisciplinary teams in behavioral medicine. Recent publications demonstrate sustained high-impact output in both clinical and basic science domains.